文献速递肿瘤 PET/CT核素与放射性配体治疗

FDG PET/CT检测肝细胞癌患者偶发发现:对考虑肝移植患者的额外获益?

FDG PET/CT to Detect Incidental Findings in Patients With Hepatocellular Carcinoma-Additional Benefit for Patients Considered for Liver Transplantation?
PubMed 文献 · Clin Nucl Med · 2021-01-01

该回顾性研究筛查了345例肝细胞癌(HCC)患者的439次FDG PET/CT检查中的偶发发现,其中81例考虑肝移植。9例(11.1%)考虑肝移植的患者因FDG PET/CT偶发发现而未进行移植。结论认为FDG PET/CT可识别HCC患者及考虑肝移植者的相关偶发发现并影响管理。

要点

  • FDG PET/CT可检出HCC患者偶发肿瘤和炎症,影响治疗策略。
  • 考虑肝移植的HCC患者中11.1%因偶发发现未移植。
  • FDG PET/CT或对其它器官移植评估也有获益。

核心结论

  • FDG PET/CT能识别HCC患者及考虑肝移植者的相关偶发发现(如第二原发恶性肿瘤、良性肿瘤和炎症),从而影响HCC患者管理。
  • FDG PET/CT可能对考虑不同器官移植的患者也有益。

研究设计与样本

  • 回顾性研究,筛查345例HCC患者的439次FDG PET/CT检查中的偶发发现。
  • 其中81例患者考虑肝移植,单独记录该亚组偶发发现的影响。

主要发现

  • 偶发发现包括22例肿瘤(其中9例恶性)和52例炎症。
  • 81例考虑肝移植的患者中,9例(11.1%)因FDG PET/CT偶发发现而未进行肝移植。

临床怎么用

  • 对HCC患者,尤其考虑肝移植者,FDG PET/CT可发现肝外偶发病变并影响治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: FDG PET/CT has been described for noninvasive grading, detection of extrahepatic spread, and recurrence in hepatocellular carcinoma (HCC). As compared with localized imaging approaches (MRI, ultrasonography), FDG PET/CT not only focuses on the liver, but covers a long field of view from the base of the skull to the thighs, visualizing pathologic findings not related to HCC. The aims of this retrospective study were to (1) describe the frequency of relevant incidental findings on FDG PET/CT in HCC patients, (2) evaluate the impact on treatment strategy in HCC patients considered for liver transplantation, and (3) to discuss the role of FDG PET/CT in patients considered for transplantation in general. METHODS: Four hundred thirty-nine FDG PET/CT examinations of 345 HCC patients were screened for incidental findings. The clinical information system was searched for examinations performed after FDG PET/CT and aimed at verification of incidental findings. Of 345 HCC patients, 81 patients were considered for liver transplantation. The impact of incidental findings was recorded separately for this subgroup. RESULTS: One hundred one patients with incidental findings in 439 FDG PET/CT examinations were identified. The incidental findings comprised 22 neoplasms (9 malignant) and 52 inflammations. Liver transplantation was not performed because of an incidental finding on FDG PET/CT in 9 (11.1%) of 81 patients. CONCLUSIONS: FDG PET/CT is capable of identifying relevant incidental findings (ie, secondary malignancy, benign tumors, and inflammation) in HCC patients and HCC patients considered for liver transplantation and thus influencing HCC patient management. FDG PET/CT might also be beneficial in patients considered for transplantation of different organs.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Winkens T, Rudakoff W, Rauchfuss F, et al. FDG PET/CT to Detect Incidental Findings in Patients With Hepatocellular Carcinoma-Additional Benefit for Patients Considered for Liver Transplantation? Clin Nucl Med. 2021. PMID: 33661197. doi:10.1097/RLU.0000000000003576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。